0 CHECKOUT

PRODUCT FILTERS

REGION

17
1
1
1

COUNTRY

1

CATEGORIES

  • 28
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

13
28
33
52

PUBLISHED

8
10
17
52

PRODUCT TYPE

24
18
10

Search for: "Cephalon Inc-Detailed Product Pipeline"

Cephalon, Inc. - Product Pipeline Review - 2012

Cephalon, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Cephalon, Inc. - Product Pipeline Review - 2012” provides data on the Cephalon, Inc.’s research...

Published:  September 2012
Price:  From

Cephalon, Inc. - Product Pipeline Review - H2 2011

Cephalon, Inc. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Cephalon, Inc. - Product Pipeline Review - H2 2011” provides data on the Cephalon, Inc.’s...

Published:  November 2011
Price:  From

Cephalon, Inc. - Strategic SWOT Analysis Review

Cephalon, Inc. - Strategic SWOT Analysis Review Summary Cephalon, Inc. (Cephalon) is a biopharmaceutical company recently acquired by Teva Pharmaceutical Industries Ltd. focuses on the research, development...

Published:  September 2012
Price:  From

Cephalon, Inc. - Product Pipeline Review - Q4 2010

Cephalon, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Cephalon, Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research...

Published:  November 2010
Price:  From

Cephalon, Inc. - Product Pipeline Review - Q4 2010

Cephalon, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Cephalon, Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research...

Published:  November 2010
Price:  From

Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

About Non-Hodgkin Lymphoma (NHL) and its Diagnostic Procedures Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances,...

Published:  June 2014
Price:  From

Cephalon, Inc. (CEPH) - Financial and Strategic SWOT Analysis Review

Cephalon, Inc. (CEPH) - Financial and Strategic SWOT Analysis Review Summary Cephalon, Inc. (Cephalon) is a biopharmaceutical company engaged in the research, development and marketing of innovative...

Published:  April 2011
Price:  From

Pharmaceutical Products of the Future: 50-Company Pipeline Analysis to 2015

What Will The Pharmaceutical Market Look Like in the Next Five Years? In this report, Kalorama has analyzed the late stage R&D pipeline of the 50 top companies in pharmaceuticals -- the companies...

Published:  July 2010
Price:  From

Global Diabetic Neuropathy Market 2014-2018

About Diabetic Neuropathy Diabetes is usually associated with progressive damage to the nervous system, which leads to disorders collectively known as diabetic neuropathy. Diabetic neuropathy is characterized...

Published:  May 2014
Price:  From

Eosinophilic Esophagitis - Pipeline Review, H1 2015

Eosinophilic Esophagitis - Pipeline Review, H1 2015 Summary This, ‘Eosinophilic Esophagitis - Pipeline Review, H1 2015’, provides an overview of the Eosinophilic Esophagitis’s therapeutic pipeline. This...

Published:  April 2015
Price:  From

Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

Published:  February 2016
Price:  From

Partial Seizure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Partial Seizure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

Published:  February 2016
Price:  From

Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas

The service oriented and dynamic nature of the healthcare industry has led to the discovery of a plethora of treatment options for a wide range of ailments.However, there are certain diseases, termed...

Published:  March 2015
Price:  From

Hodgkin Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Hodgkin Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

Published:  February 2016
Price:  From

Cancer Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Cancer Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

Published:  February 2016
Price:  From

Non-Hodgkin Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Non-Hodgkin Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the...

Published:  February 2016
Price:  From

Chronic Lymphocytic Leukemia (CLL)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Chronic Lymphocytic Leukemia (CLL)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs...

Published:  February 2016
Price:  From

Narcolepsy Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Narcolepsy- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

Published:  February 2016
Price:  From

Alkermes, Inc. - Product Pipeline Review - Q2 2011

Alkermes, Inc. – Product Pipeline Review – Q2 2011 Summary Global Market Direct’s pharmaceuticals report, “Alkermes, Inc. - Product Pipeline Review - Q2 2011” provides data on the Alkermes, Inc.’s...

Published:  July 2011
Price:  From

Alkermes, Inc. - Product Pipeline Review - Q4 2010

Alkermes, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Alkermes, Inc. - Product Pipeline Review - Q4 2010” provides data on the company’s research...

Published:  November 2010
Price:  From
Loading Indicator

Our Clients

  • Goodyear Tire & Rubber Company
  • GlaxoSmithKline PLC
  • Hilton Worldwide
  • Hewlett-Packard Company
  • Accenture PLC.
  • Qualcomm Incorporated
  • UBS AG